Market Place
Sourcing Support
Attralus Presents Data on Pan-Amyloid Diagnostics at ACC Session
01 Apr 2025 //
GLOBENEWSWIRE
Attralus Begins Crucial Phase In Cardiac Treatment Research
15 Jan 2025 //
GLOBENEWSWIRE
Attralus AT-02 Get FDA Orphan Drug Designation for ATTR Amyloidosis
12 Nov 2024 //
GLOBENEWSWIRE
Attralus Gets Breakthrough Therapy For Pan-Amyloid Diagnostic PET Imaging
05 Aug 2024 //
GLOBENEWSWIRE
Attralus Receives EMA COMP Positive Opinions For AT-02
29 Jul 2024 //
GLOBENEWSWIRE
Attralus Presents Amyloid Therapeutic And Diagnostic Data At ISA
30 May 2024 //
GLOBENEWSWIRE
Attralus Closes $56 Million Financing
06 Feb 2024 //
GLOBENEWSWIRE
Attralus Announces Publication of Studies Evaluating Iodine (124I) Evuzamitide
07 Nov 2023 //
GLOBENEWSWIRE
Attralus Announces Presentation of Clinical Data for 124I-Evuzamitide (AT-01)
02 Oct 2023 //
GLOBENEWSWIRE
Attralus Presents New Preclinical Data on AT-04 and AT-07
03 Apr 2023 //
GLOBENEWSWIRE
Attralus Receives FDA and EMA Orphan Designation for AT-01
19 Dec 2022 //
GLOBENEWSWIRE
Attralus &Ossianix Announce an Option and License Agreement using the TXP1
17 Nov 2022 //
GLOBENEWSWIRE
Attralus doses first subject in Phase I pan-amyloid removal therapy trial
17 Oct 2022 //
CLINICALTRIALSARENA
Attralus Announces First Subject Enrolled in Phase 1 Clinical Trial of AT-02
17 Oct 2022 //
GLOBENEWSWIRE
Attralus Announces New Clinical Data in ATTR CM and AL With AT-01
12 Sep 2022 //
GLOBENEWSWIRE
Attralus Presents In Vivo Preclinical Data for AT-02 Significant Amyloid
06 Sep 2022 //
GLOBENEWSWIRE
Attralus Announces New Preclinical Demonstrating Novel Human Chimeric (CAR-M)
06 Sep 2022 //
GLOBENEWSWIRE
Attralus to Present New Data on Amyloidosis Portfolio
22 Aug 2022 //
GLOBENEWSWIRE
Attralus Receives U.S. FDA ODD for AT-01 for Transthyretin Amyloidosis
08 Aug 2022 //
GLOBENEWSWIRE
Attralus to Present New AT-01 Data at Society of NMMI
03 Jun 2022 //
GLOBENEWSWIRE
Biopharma Company Earns Fresh Funds to Push PAR Therapeutics to Clinic
08 Sep 2021 //
BIOSPACE
Attralus Announces Presentation of Clinical Data on AT-01
15 Jun 2021 //
BUSINESSWIRE
Attralus Announces Presentation of Clinical Data on AT-01, a Novel
17 May 2021 //
BUSINESSWIRE
Attralus Announces Presentation of Clinical Data on AT-01, a Nove
17 May 2021 //
BIOSPACE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.